Healthcare It News

SEPTEMBER 27, 2024

Biotechnology company Amgen Australia has backed its development. It exports detailed psoriasis patient lists, which are categorised by severity and treatment type. The dashboard is also informed by the updated Australian consensus on treating moderate to severe psoriasis.

Biotechnology 306

Biotechnology Nursing Medicare Healthcare Providers 306

HIT Consultant

OCTOBER 31, 2024

What You Should Know: – Accenture has made a strategic investment, through Accenture Ventures , in 1910 Genetics , a biotechnology company revolutionizing drug discovery with its AI-powered platform. Terms of the investment were not disclosed.

Biotechnology 103

Biotechnology Integration Life Sciences 103

Bill Of Health

FEBRUARY 7, 2023

Banning non-compete clauses may help to promote competition and innovation in biotechnology and health care. Currently, there is a high degree of knowledge concentration in new and evolving technologies in the biotechnology sector.

Biotechnology 85

Biotechnology Prevention Regulations 85

The Rand Blog

MARCH 21, 2024

Machine learning is helping scientists make sense of the genetic keys that could unlock new crops, new drugs, and vaccines. But policymakers may not be prepared for the impact those two fields could have together. To make the most of the opportunities to come, and to avoid the dangers, that has to change.

Biotechnology 108

Biotechnology 108

HIT Consultant

MARCH 24, 2025

What You Should Know: – 23andMe , a human genetics and biotechnology company, has announced its decision to initiate voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri. – The bankruptcy filing is aimed at facilitating a structured sale process to maximize the value of its business.

Biotechnology 105

Biotechnology Accountability 105

HIT Consultant

NOVEMBER 14, 2024

With more than twenty-five years of experience in biotechnology, Noah brings a broad background in developing and commercializing novel technology to advance human health, including serving as the CEO of Serimmune and Chief Commercial Officer roles at Human Longevity and Counsyl.

Biotechnology 105

Biotechnology Pharmaceuticals Clinical Practice Healthcare 105

Healthcare It News

SEPTEMBER 9, 2022

It is funded through the state's Australian Medtech Manufacturing Centre and Biotechnology Fund and is being delivered by digital health accelerator ANDHealth. Programme to support clinical entrepreneurs launched in WA. A new programme to support clinical entrepreneurs has been launched in Western Australia.

Biotechnology 244

Biotechnology Doctors Hospitals Healthcare 244

HIT Consultant

APRIL 24, 2025

Immunai Expands AMICA with Industrys Largest Real-World Single-Cell Dataset in Immuno-Oncology Immunai, a biotechnology company leveraging single-cell genomics and machine learning to transform therapeutic development, has announced a major expansion of its AMICA (Annotated Multi-omic Immune Cell Atlas) platform.

Biotechnology 71

Biotechnology Pharmaceuticals Clinical Practice Integration 71

HIT Consultant

JUNE 12, 2023

What You Should Know: Range Biotechnologies (Range Bio) announced $5.2M in seed funding, led by TechBio-focused ARTIS Ventures with participation from Pear VC , Page One Ventures , Civilization Ventures , Pillar , Four Cities Capital , Hawktail , and others.

Biotechnology 52

Biotechnology Prevention Life Sciences 52

Bill Of Health

MAY 28, 2025

About the authors Shelly Simana is an assistant professor at Boston College Law School, specializing in the intersection of bioethics and law, addressing ethical and legal challenges that arise as a consequence of scientific advancements in genetics, reproductive technologies, and biotechnology.

Biotechnology 80

Biotechnology 80

HIT Consultant

JANUARY 29, 2025

What You Should Know: – OSE Immunotherapeutics SA, a biotechnology company focused on developing innovative immunotherapies, and Scienta Lab , a pioneer in AI-driven precision immunology is forming a strategic collaboration to leverage the power of artificial intelligence (AI) in the fight against inflammatory diseases.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

JUNE 17, 2025

With more than twenty-five years of experience in biotechnology, Noah brings a broad background in developing and commercializing novel technology to advance human health, including serving as the CEO of Serimmune and Chief Commercial Officer roles at Human Longevity and Counsyl.

Pharmaceuticals 80

Pharmaceuticals Biotechnology Patient Experience Clinical Practice 80

The Rand Blog

DECEMBER 29, 2023

The Saudis have set their sights on becoming leaders at the cutting edge of technology development in everything from biotechnology to semiconductors and artificial intelligence. And they appear to be prepared to pay top dollar to do it. This complicates U.S. critical technology strategy.

Biotechnology 109

Biotechnology 109

HIT Consultant

DECEMBER 16, 2024

Yifat Merbls lab at the Weizmann Institute and published in Nature Biotechnology in 2023, allows high-throughput profiling of dozens of PTMs using mass spectrometry. At the core of Promise Bios success is its proprietary PROMISE (Protein Modification Integrated Search Engine) platform, developed by Co-Founder & CTO Dr. Assaf Kacen.

Biotechnology 52

Biotechnology Integration Life Sciences 52

HIT Consultant

OCTOBER 13, 2022

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

Biotechnology 98

Biotechnology Regulations Prevention Integration 98

Bill Of Health

DECEMBER 9, 2024

artwork by Daiara Tukano by Daiara Tukano and Maria Fernanda Gebara Last June, we had the honor of speaking at Law and Policy of Psychedelic Medicine, the 2024 Annual Conference hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. You can watch our panel here.

Biotechnology 85

Biotechnology Integration Pharmaceuticals Regulations 85

HIT Consultant

AUGUST 26, 2024

OTCQB: HRGN) , a clinical-stage biotechnology company focused on developing organ regeneration technology for severe diseases, has secured approximately $5 million from a new investor through a private placement of shares. What You Should Know: – Harvard Apparatus Regenerative Technology, Inc.

Biotechnology 97

Biotechnology Life Sciences 97

Bill Of Health

DECEMBER 11, 2023

Luciano Bottini Filho is a Lecturer in Human Rights at Sheffield Hallam University and Affiliated Researcher with the Global Health and Human Rights Project at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.

Biotechnology 131

Biotechnology Pharmaceuticals Doctors 131

HIT Consultant

JULY 8, 2025

The leadership team combines deep scientific expertise with proven execution in biotechnology. “Our platform’s versatility enables us to tackle a spectrum of rapidly mutating targets, from viruses to venom toxins.”

Biotechnology 52

Biotechnology Pharmaceuticals Life Sciences 52

HIT Consultant

APRIL 8, 2025

Source: MyPhenome genetic obesity test What You Should Know: – Phenomix Sciences (Phenomix) , a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical study.

Biotechnology 52

Biotechnology Pharmaceuticals Healthcare Providers Healthcare 52

HIT Consultant

NOVEMBER 18, 2021

Benchling’s growth is fueled by the rapid rise of biotechnology , one of the world’s fastest-growing industries. As biotechnology companies come under increased pressure to deliver breakthroughs, they are turning to modern software to digitize all their scientific processes and centralize their data. Recent Traction/Milestones.

Biotechnology 97

Biotechnology Life Sciences Pharmaceuticals Accountability 97

Bill Of Health

FEBRUARY 18, 2025

It provides tailored legal and regulatory support to patients, researchers, businesses, and incubators, driving progress in healthcare and biotechnology. Another main study in this key area involves the study of biotechnologies and so-called biosolutions. We recently published a study for the European Commission on these issues.

Life Sciences 52

Life Sciences Biotechnology Pharmaceuticals Regulations 52

HIT Consultant

MARCH 30, 2023

What You Should Know: – Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces today the launch of its first therapy selection test, the My Phenome Hungry Gut test.

Biotechnology 96

Biotechnology 96

HIT Consultant

OCTOBER 14, 2022

Obatala Sciences, a New Orleans biotechnology company, was founded in 2017 to enable diversity in clinical research and speed up the development of better therapies for diseases like obesity, diabetes, and cancer, and advance research in tissue engineering and regenerative medicine. Trivia Frazier, Ph.D.,

Biotechnology 98

Biotechnology Pharmaceuticals Healthcare Innovation Prevention 98

HIT Consultant

APRIL 6, 2023

a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Implant raises $6M from new and existing investors in a private placement of its shares of common stock. What You Should Know: Biostage, Inc.,

Biotechnology 98

Biotechnology Life Sciences 98

Bill Of Health

OCTOBER 17, 2023

It seems, in the near term, that the “who” would probably be a venture-backed biotechnology company — a corporate actor. Open questions abound for cell-based testing services, but perhaps the first among them would be: who would offer them?

Biotechnology 113

Biotechnology Regulations Medical Technology 113

HIT Consultant

NOVEMBER 2, 2022

Dr. Squinto joins from OrbiMed Advisors and brings more than 30 years of experience in the biotechnology company building and investing space, having co-founded and built numerous biotechnology companies including Alexion Pharmaceuticals and acting as a key scientific founder of Regeneron Pharmaceuticals. Joining Dr.

Life Sciences 98

Life Sciences Biotechnology Pharmaceuticals Healthcare 98

HIT Consultant

OCTOBER 7, 2021

The firm is continuing to add new pharmaceutical and biotechnology companies to its client base, in new therapeutic areas, and has continued to expand with the addition of over 100 new employees so far in 2021.

Biotechnology 97

Biotechnology Pharmaceuticals Life Sciences 97

HIT Consultant

JANUARY 3, 2022

HCS), a company focused on helping patients adhere to and benefit from pharmaceutical and biotechnology products. CareMetx, LLC, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced today the acquisition of Human Care Systems, Inc.

Biotechnology 98

Biotechnology Pharmaceuticals Healthcare 98

HIT Consultant

OCTOBER 18, 2024

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces a new partnership to advance precision medicine in obesity with InformedDNA, the nation’s leading applied genomics solutions company.

Integration 105

Integration Life Sciences Biotechnology Healthcare 105

HIT Consultant

SEPTEMBER 29, 2023

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company that brings data-driven precision medicine to obesity treatment, announced it has been awarded the first patent related to its obesity phenotyping technology. – The patent (No.

Biotechnology 105

Biotechnology Life Sciences 105

HIT Consultant

DECEMBER 8, 2022

What You Should Know: – Vevo Therapeutics , an SF-based biotechnology company, launched today with a $12M seed round led by General Catalyst and Wing Venture Capital using its Mosaic in vivo drug discovery platform and next-generation AI models to uncover better drugs for more patients.

Biotechnology 97

Biotechnology Life Sciences 97

Bill Of Health

JUNE 16, 2023

Panelists discussed these topics during a recent webinar hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. By Minsoo Kwon The legalization of cannabis has raised ethical, regulatory, and scientific questions. This article highlights key points made during the conversation.

Biotechnology 105

Biotechnology Regulations Hospitals 105

Home Health Care

MAY 28, 2025

Furthermore, researchers found that the typical hours dedicated to professional and non-professional caregiving can reach up to 130 hours per week, depending on the stage of the disease, according to a study on health care resource use by researchers at Biogen, a biotechnology company based in Cambridge, Massachusetts.

Home Care 70

Home Care Nursing Medicare Medicaid 70

Bill Of Health

DECEMBER 6, 2024

Cohens work was supported by a Novo Nordisk Foundation Grant for a scientifically independent International Collaborative Bioscience Innovation & Law Programme (Inter-CeBIL programme – grant no.

Regulations 72

Regulations Biotechnology Accountability Healthcare 72

HIT Consultant

OCTOBER 10, 2024

Glook Appoints Mike Alvarez as Chief Executive Officer Mike Alvarez, CEO at Glooko Mike Alvarez brings over 20 years of leadership experience in the medical device and biotechnology industries to his role as CEO of Glooko.

Biotechnology 98

Biotechnology Integration Healthcare 98

HIT Consultant

MAY 25, 2022

Pleno is based in San Diego’s Sorrento Mesa innovation hub proximate to a robust talent pool of experienced scientists, telecommunication engineers, and biotechnology innovators. The company currently employs 14 full-time employees and plans to rapidly grow its team in the coming months.

Biotechnology 98

Biotechnology Life Sciences 98